Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
4.650
-0.200 (-4.12%)
At close: Jul 3, 2025, 1:00 PM
4.630
-0.020 (-0.43%)
After-hours: Jul 3, 2025, 4:29 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K